PubRank

Raffi Bekeredjian

Author PubWeight™ 62.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation 2012 3.30
2 Knowledge discovery by automated identification and ranking of implicit relationships. Bioinformatics 2004 2.42
3 Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest 2013 2.23
4 Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors. Cardiovasc Res 2009 1.67
5 Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A 2006 1.57
6 Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci Transl Med 2011 1.54
7 Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003 1.54
8 Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol 2009 1.46
9 Objective quantification of aortic valvular structures by cardiac computed tomography angiography in patients considered for transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013 1.45
10 Ultrasonic gene and drug delivery to the cardiovascular system. Adv Drug Deliv Rev 2008 1.45
11 Evidence of left ventricular contractile asynchrony by echocardiographic phase imaging in patients with type 2 diabetes mellitus and without clinically evident heart disease. Am J Cardiol 2006 1.44
12 Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy. JACC Cardiovasc Imaging 2009 1.41
13 Experts and beginners benefit from three-dimensional echocardiography: a multicenter study on the assessment of mitral valve prolapse. J Am Soc Echocardiogr 2013 1.39
14 Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res 2006 1.22
15 Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin Drug Deliv 2008 1.20
16 Microbubbles as ultrasound triggered drug carriers. J Pharm Sci 2009 1.16
17 New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J Control Release 2010 1.10
18 Innovations in phenotyping of mouse models in the German Mouse Clinic. Mamm Genome 2012 1.09
19 MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail 2012 1.09
20 The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation? Clin Res Cardiol 2012 1.07
21 Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 2005 1.07
22 Transcatheter aortic valve implantation after previous mechanical mitral valve replacement: expanding indications? Heart Surg Forum 2011 1.05
23 Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. EuroIntervention 2013 1.03
24 Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des 2012 1.02
25 Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve(®) aortic bioprosthesis. Clin Res Cardiol 2011 0.96
26 Endogenous endothelin-1 is required for cardiomyocyte survival in vivo. Circulation 2006 0.93
27 Real-time myocardial perfusion imaging for pharmacologic stress testing: added value to single photon emission computed tomography. Am Heart J 2006 0.92
28 Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. PLoS One 2012 0.92
29 Long-term preservation of cardiac structure and function after adeno-associated virus serotype 9-mediated microdystrophin gene transfer in mdx mice. Hum Gene Ther 2012 0.91
30 Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy. Int J Cardiol 2006 0.88
31 Feasibility and clinical benefit of a suture-mediated closure device for femoral vein access after percutaneous edge-to-edge mitral valve repair. EuroIntervention 2015 0.88
32 New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization. J Control Release 2010 0.88
33 Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology. FASEB J 2012 0.87
34 Evaluation of myocardial perfusion and deformation in patients with acute myocardial infarction treated with primary angioplasty and stent placement. Coron Artery Dis 2008 0.86
35 Ultrasound exposure can increase the membrane permeability of human neutrophil granulocytes containing microbubbles without causing complete cell destruction. Ultrasound Med Biol 2006 0.85
36 Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimetic. Lab Invest 2009 0.85
37 Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability. Ultrasound Med Biol 2009 0.84
38 Atrial natriuretic peptide and osteopontin are useful markers of cardiac disorders in mice. Comp Med 2007 0.83
39 Predictors for short-term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function. EuroIntervention 2016 0.83
40 Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis. Clin Res Cardiol 2013 0.82
41 Adeno-associated virus vector delivery to the heart. Methods Mol Biol 2011 0.82
42 Impact of the learning curve on outcome after transcatheter mitral valve repair: results from the German Mitral Valve Registry. Clin Res Cardiol 2014 0.81
43 One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip implantation. Eur J Heart Fail 2013 0.81
44 High-throughput phenotypic assessment of cardiac physiology in four commonly used inbred mouse strains. J Comp Physiol B 2014 0.81
45 C-reactive protein kinetics and its prognostic value after transfemoral aortic valve implantation. J Invasive Cardiol 2012 0.80
46 The potential of a new stable ultrasound contrast agent for site-specific targeting. An in vitro experiment. Ultrasound Med Biol 2006 0.79
47 Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients. Am J Cardiol 2011 0.79
48 Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials. J Thromb Thrombolysis 2002 0.79
49 Percutaneous and surgical treatment of mitral valve regurgitation. Dtsch Arztebl Int 2011 0.79
50 The heart in Duchenne muscular dystrophy: early detection of contractile performance alteration. J Cell Mol Med 2012 0.78
51 MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation. Arterioscler Thromb Vasc Biol 2015 0.78
52 Usefulness of real-time myocardial perfusion imaging to evaluate tissue level reperfusion in patients with non-ST-elevation myocardial infarction. Am J Cardiol 2005 0.78
53 Percutaneous edge-to-edge repair of mitral regurgitation as a bail-out strategy in critically ill patients. J Invasive Cardiol 2013 0.78
54 Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function. Am J Nephrol 2013 0.78
55 Quantitative myocardial blush grade for the detection of cardiac allograft vasculopathy. Am Heart J 2010 0.78
56 Coronary angiography-related myocardial injury as detected by high-sensitivity cardiac troponin T assay. EuroIntervention 2016 0.77
57 Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters. Clin Res Cardiol 2014 0.77
58 Fourier phase analysis can be used to objectively analyze real-time myocardial contrast echocardiograms. Int J Cardiovasc Imaging 2004 0.77
59 Ex vivo coronary angiography of a donor heart in the organ care system. Heart Surg Forum 2012 0.77
60 First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome. J Interv Cardiol 2015 0.77
61 Impact of tricuspid valve regurgitation in surgical high-risk patients undergoing MitraClip implantation: results from the TRAMI registry. EuroIntervention 2017 0.77
62 Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis. Case Rep Med 2011 0.76
63 Whole-genome analysis of gene expression associates the ubiquitin-proteasome system with the cardiomyopathy phenotype in disease-sensitized congenic mouse strains. Cardiovasc Res 2012 0.76
64 The Effects of Mitral Valve Repair on Memory Performance, Executive Function, and Psychological Measures in Patients With Heart Failure. Psychosom Med 2016 0.76
65 Detection of acute myocardial ischemia during pharmacological stress in graded coronary artery stenosis: analysis of left ventricular asynchrony using Fourier phase imaging in pigs. Int J Cardiovasc Imaging 2003 0.75
66 Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System. J Invasive Cardiol 2016 0.75
67 Effects of the high-affinity Peptide reversin 121 on multidrug resistance proteins in experimental pancreatic cancer. Tumour Biol 2008 0.75
68 Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation. EuroIntervention 2017 0.75
69 Prognostic implications of coronary artery stenosis and coronary spasm in patients with stable angina: 5-year follow-up of the Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries (ACOVA) study. Coron Artery Dis 2020 0.75
70 Haemophilia-associated Yersinia pseudotuberculosis serotype O:1 septicaemia: the role of iron. J Med Microbiol 2012 0.75
71 Combined Mitro-Aortic Pathology: Impact Of Previous Aortic Valve Replacement Upon Outcomes Of Mitra-Clip Therapy. EuroIntervention 2017 0.75
72 Cardioprotective effects of the novel selective endothelin-A receptor antagonist BSF 461314 in ischemia-reperfusion injury. J Am Soc Echocardiogr 2005 0.75
73 Erratum to: High throughput phenotyping of left and right ventricular cardiomyopathy in calcineurin transgene mice. Int J Cardiovasc Imaging 2015 0.75
74 Technical challenge of transfemoral aortic valve implantation in a patient with severe aortic regurgitation. Circ Cardiovasc Interv 2011 0.75
75 Activation of PPARgamma by pioglitazone does not attenuate left ventricular hypertrophy following aortic banding in rats. Naunyn Schmiedebergs Arch Pharmacol 2010 0.75
76 High throughput phenotyping of left and right ventricular cardiomyopathy in calcineurin transgene mice. Int J Cardiovasc Imaging 2015 0.75
77 Successful MitraClipTM implantation in a 15-year-old patient with multiple prior cardiac surgeries. Cardiol Young 2012 0.75
78 Procedural results with the self-expanding 31 mm CoreValve aortic bioprosthesis in patients with large annuli. J Interv Cardiol 2014 0.75
79 Effects of atrial fibrillation and heart rate on percutaneous mitral valve repair with MitraClip: results from the TRAnscatheter Mitral valve Interventions (TRAMI) registry. EuroIntervention 2017 0.75
80 Images and case reports in interventional cardiology. Percutaneous aortic "valve in valve" implantation for severe aortic regurgitation in a degenerated bioprosthesis. Circ Cardiovasc Interv 2010 0.75
81 Improved procedural results after CoreValve implantation with the new AccuTrak delivery system. J Interv Cardiol 2012 0.75